Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promotedin the centers for disease control and prevention 2012 carbapenemase-resistant enterobacteriaceae toolkit

Infection Control and Hospital Epidemiology

Volumn 35, Issue 7, 2014, Pages 810-817

  Enfield, Kyle B ^a,b   Huq, Nujhat N ^a   Gosseling, Megan F ^b   Low, Darla J ^b   Hazen, Kevin C ^a   Toney, Denise M ^c   Slitt, Gavin ^a   Zapata, Heidi J ^a   Cox, Heather L ^a   Lewis, Jessica D ^a   Kundzins, John R ^a   Mathers, Amy J ^a   Sifri, Costi D ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c Division of Infectious Diseases and International Health Department of Medicine University of Virginia Health System ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BIOLUMINESCENCE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE INFECTION; CLINICAL ARTICLE; DISEASE CARRIER; DISEASE SURVEILLANCE; ENTEROBACTERIACEAE INFECTION; EXTENSIVELY DRUG RESISTANT ACINETOBACTER BAUMANNII INFECTION; GENETIC ANALYSIS; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE UNIT; NONHUMAN; POLYMERASE CHAIN REACTION; PUBLIC HEALTH SERVICE; PULSED FIELD GEL ELECTROPHORESIS; SCREENING; TIME SERIES ANALYSIS; ACINETOBACTER INFECTIONS; COMPARATIVE STUDY; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ISOLATION AND PURIFICATION; MULTIDRUG RESISTANCE; OUTCOME ASSESSMENT; PROCEDURES; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; CARBAPENEMS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; OUTCOME ASSESSMENT (HEALTH CARE); UNITED STATES; VIRGINIA;

EID: 84902993798     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/676857     Document Type: Article

References (19)

1. Peleg AY, Hooper DC. Hospital-acquired infections due to gramnegative bacteria. N Engl J Med 2010;362:1804-1813.
2. Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008;8:751-762.
3. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011;53:60-67.
4. Centers for Disease Control and Prevention. 2012 CRE toolkit: guidance for control of carbapenem-resistance Enterobacteriaceae (CRE). http://www.cdc.gov/hai/organisms/cre/cre-toolkit/. Accessed January 5, 2013.
5. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-281.
6. Rutala WA, Weber DJ; Healthcare Infection Control Practice Advisory Committee (HICPAC). Guideline for disinfection and sterilization in healthcare facilities, 2008. http://www.cdc.gov hicpac/DisinfectionSterilization/acknowledg.html. Accessed January 12, 2013.
7. World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology. ATC/DDD index 2013. http:// ww.whocc.no/atc_ddd_index/. Accessed November 29, 2013.
8. Mathers AJ, Cox HL, Kitchel B, et al. Molecular dissection of an outbreak of carbapenem-resistant Enterobacteriaceae reveals intergenus KPC carbapenemase transmission through a promiscuous plasmid. MBio 2011;2:e00204-e00211.
9. Mathers AJ, Carroll J, Sifri CD, Hazen KC. Modified Hodge test versus indirect carbapenemase test: prospective evaluation of a phenotypic assay for detection of Klebsiella pneumoniae carbapenemase (KPC) in Enterobacteriaceae. J Clin Microbiol 2013; 51:1291-1293.
10. Mathers AJ, Hazen KC, Carroll J, et al. First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the menace arrives in the new world. J Clin Microbiol 2013;51:680-683.
11. Mathers AJ, Poulter M, Dirks D, Carroll J, Sifri CD, Hazen KC. Clinical microbiology costs for methods of active surveillance for Klebsiella pneumoniae carbapenemase (KPC) producing Enterobacteriaceae Infect Control Hosp Epidemiol 2014;35(4):350-355.
12. Ribot EM, Fair MA, Gautom R, et al. Standardization of pulsedfield gel electrophoresis protocols for the subtyping of Escherichia coli O157: H7,Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 2006;3:59-67.
13. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.
14. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27:299-309.
15. McCullagh P. Quasi-likelihood functions. Ann Statist 1983;11: 59-67.
16. Mathers AJ, Cox HL, Bonatti H, et al. Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients. Transpl Infect Dis 2009;11:257-265.
17. Swaminathan M, Sharma S, Poliansky Blash S, et al. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol 2013;34:809-817.
18. Corbella X, Pujol M, Ayats J, et al. Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin Infect Dis 1996; 23:329-334.
19. Jung JY, Park MS, Kim SE, et al. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis 2012;10:228.